Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001697482 | SCV000720139 | likely benign | not provided | 2021-04-09 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000634826 | SCV000756170 | likely benign | Alstrom syndrome | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002331047 | SCV002629429 | likely benign | Cardiovascular phenotype | 2020-10-28 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000634826 | SCV003800079 | likely benign | Alstrom syndrome | 2022-03-08 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003330823 | SCV004038192 | likely benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001697482 | SCV004154989 | likely benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | ALMS1: BP4, BP7 |